Sunday 19 May, 2024 12:01 AM
Site map | Locate Us | Login
   Kirloskar Ferrous Q4 PAT drops 81% YoY to Rs 18 cr    ZEEL reports turnaround Q4 numbers    NHPC Q4 PAT slides 18% to Rs 610 cr    Nestle India ends higher after public shareholders reject royalty hike proposal to Swiss parent    Sobha Q4 PAT drops 85% YoY to Rs 7 cr    Kirloskar Ferrous Industries Ltd leads losers in 'A' group    Vindhya Telelinks Ltd leads losers in 'B' group    Volumes soar at MTAR Technologies Ltd counter    Godrej Inds slides on reporting net loss of Rs 312 cr in Q4    Granules India Ltd gains for third consecutive session    Glenmark Pharmaceuticals Ltd up for third straight session    Aurobindo Pharma Ltd spurts 3.21%    National Aluminium Company Ltd gains for third straight session    Zee Entertainment Enterprises Ltd spurts 4.37%    Ashok Leyland Ltd up for third consecutive session 
Saravan Stocks
       
Company News
Remus Pharmaceuticals Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R)
78788 INE0O5T01011 557.1147318 REMUS 0.03 1154.83 68.66 114.19 10
Date Headline
10-May-2024 Remus Pharmaceuticals to table results
24-Apr-2024 Remus Pharmaceuticals schedules EGM
20-Apr-2024 Remus Pharmaceuticals revises board meeting date
17-Apr-2024 Remus Pharmaceuticals to consider Dividend
15-Feb-2024 Remus Pharmaceuticals to convene EGM
07-Feb-2024 Remus Pharmaceuticals Ltd - Acquisition
07-Feb-2024 Remus Pharmaceuticals Ltd - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
07-Feb-2024 Remus Pharmaceuticals Ltd - Change in Auditors
07-Feb-2024 Remus Pharmaceuticals Ltd - Resignation of Statutory Auditor
07-Feb-2024 Remus Pharmaceuticals Ltd - Updates
1 2 
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Span Margin | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR Hit Count : 32680012
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd